Effect of nebivolol on endothelial dysfunction in patients with Behcet's disease; a prospective single-arm controlled study

Creative Commons License

Akkaya H., Sahin O., BORLU M., OĞUZHAN A., KARAKAS M. S.

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.13, no.2, pp.115-120, 2013 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.5152/akd.2013.034
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.115-120
  • Erciyes University Affiliated: Yes

Abstract

Objective: Behcet's disease (BD) is a systemic vasculitis, capable of involving all types of vessels. Endothelial dysfunction (ED) has been previously documented in BD. Previous studies showed that nebivolol might improve endothelial functions in endothelial dysfunction. The aim of our study is to assess the effects of nebivolol on endothelial dysfunction in patients with Behcet's disease.